Aastrom Biosciences and Cobe begin cell production trial:
This article was originally published in Clinica
Executive Summary
Aastrom Biosciences and Cobe are beginning a clinical trial in Marseilles, France, to evaluate the use of Aastrom's cell production system. The system is being used to produce bone marrow stem cells which promote the recovery of white blood cells in breast cancer patients undergoing aggressive multiple-cycle myelosuppressive chemotherapy. Aastrom, based in Ann Arbor, Michigan, is also carrying out US trials to evaluate its system for the same indication.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.